[The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis (author's transl)].
A randomized double-blind study about the therapy of the cirrhosis of the liver shows a significant higher surviving rate of the alcoholic cirrhosis in the group treated with Silymarin. This result can be well explained by the protective influence of this substance against toxic injuries. The etiology of many chronic liver diseases is uncertain and therefore it is advisable to try the therapy also in other cases. The conditions of the study are exactly reported. The influence on the clinic of the disease and on the laboratory data obtained in many controls will be published later, because the statistical analysis needs some more time.
D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005419:Flavonoids / Q000627:therapeutic use*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000401:mortality; D008104:Liver Cirrhosis, Alcoholic / Q000188:drug therapy / Q000401:mortality; D011897:Random Allocation; D012838:Silymarin / Q000627:therapeutic use*
D005419:Flavonoids; D012838:Silymarin
Zur Wirksamkeit von Silymarin auf die Uberlebensrate von Patienten mit Leberzirrhose.